Eiffel restructuring leads to modest half-year
13 March, 2002 by Tanya HollisBioengineering group Eiffel Technologies (ASX: EIF) has posted a more than three per cent fall in after-tax profits to $777,000 for the second half of last year.
Biotechs may find VC funding hard to get
11 March, 2002 by Salvatore SalamoneBioinformatics, biotech and nanotechnology companies seeking venture capital funding may have to look elsewhere, according to speakers at the Silicon Alley Breakfast Club (SABC) meeting held in New York last week (March 7).
Group to assess platform tech needs
11 March, 2002 by Tanya HollisA government committee set up to assess Victoria's platform technology needs is expected to report its findings by mid-year.
Mixed results for Vita Life Sciences
08 March, 2002 by Tanya HollisBiopharmaceutical manufacturer and distributor Vita Life Sciences (ASX:VLS) posted a full-year revenue drop today because of a reduced sales forecast in its key Asian markets.
Micromedical's one-day fundraising spree
08 March, 2002 by Tanya HollisArtificial heart company MicroMedical Industries raised almost $11 million in just over 24 hours through a share placement directed at new investors.
Launched: the guide to avoiding ethical debate
08 March, 2002 by Tanya HollisA handbook to help clarify the decision-making process of research ethics committees was today launched by the Federal Health and Ageing Minister.
Networking event for young biotech
08 March, 2002 by Iain ScottA new group within industry association AusBiotech is about to host its first networking event.
Fenner, innovators honoured
08 March, 2002 by Tanya HollisWorld-renowned microbiologist Prof Frank Fenner was last night (March 7) honoured with a prestigious lifetime contribution award from the Ian Clunies Ross Memorial Foundation.
Equity-minded researchers punished by tax laws
07 March, 2002 by Pete YoungHarsh tax treatment of research institute scientists trying to commercialise their inventions is harming Australia's national interests, bio-industry leaders warn.
Dear Minister: research must continue
07 March, 2002 by Melissa TrudingerAustralian scientists and scientific organisations are lobbying the Federal government in an effort to persuade them to continue to allow stem cell research using spare IVF embryos.
Biotechs to be affected by new Vic privacy laws
07 March, 2002 by Tanya HollisVictoria's new health privacy legislation would substantially impact upon the local biotechnology industry, a leading lawyer has predicted.
Brandon boosts Prima board
07 March, 2002 by Tanya HollisGenetics and immunology specialist Dr Malcolm Brandon was today named chairman of Prima Biomed's (ASX:PRR) scientific advisory panel.
Give biotechs a break: tax study
06 March, 2002 by Melissa TrudingerBiotechs need better tax breaks, according to a new report.
Former PPL director Colman joins ES Cell
05 March, 2002 by Tanya HollisEmbryonic stem cell researcher ES Cell International (ESI) has announced five senior management positions as it gears up for its development phase.
Vics look overseas to fill top job
05 March, 2002 by Tanya HollisOffshore candidates are likely to be prime contenders for the Victorian Government's newly created position of director of biotechnology.
